Literature DB >> 15135579

Fine-tuning Food Safety Objectives and risk assessment.

Arie H Havelaar1, Maarten J Nauta, Jaap T Jansen.   

Abstract

Food Safety Objectives (FSOs) have been proposed as a practical tool to translate public health targets for food safety into tolerable levels of pathogens in a food product. The FSO concept is subject to intensive debate, and has not been developed in detail. We evaluate the proposed definition of FSOs and their implementation from the perspective of Quantitative Microbiological Risk Assessment (QMRA). The relationship between QMRA and FSOs is illustrated by a model for the public health risk of Shiga-producing Escherichia coli in steak tartare. We conclude that the proposed definition of FSOs needs to be modified to properly account for variability in and uncertainty about the contamination of food with pathogenic microorganisms and emphasize that both prevalence and concentration of pathogens must be considered. For this purpose, we propose the P-D equivalence curve, a simple graphical tool to separate "tolerable" from "non-tolerable" combinations of prevalence and concentration (dose). Copyright 2003 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135579     DOI: 10.1016/j.ijfoodmicro.2003.09.012

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  3 in total

Review 1.  The food safety management system.

Authors:  M L Stecchini; M Del Torre
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

Review 2.  The formation of Staphylococcus aureus enterotoxin in food environments and advances in risk assessment.

Authors:  Jenny Schelin; Nina Wallin-Carlquist; Marianne Thorup Cohn; Roland Lindqvist; Gary C Barker; Peter Rådström
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

3.  Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia.

Authors:  Paola Marcato; Thomas P Griener; George L Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.